Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidism

Ni, ZhaohuiZhaohuiNiLiang, XinlingXinlingLiangWu, Chia-ChaoChia-ChaoWuJin, KyubokKyubokJinKim, Yong-LimYong-LimKimLu, Kuo-ChengKuo-ChengLuChan, Tak MaoTak MaoChanFukagawa, MasafumiMasafumiFukagawaKinoshita, JunJunKinoshitaNagai, ChisatoChisatoNagaiKojima, MasahiroMasahiroKojimaYu, XueqingXueqingYuOrchestra Study GroupVIN-CENT WUJENQ-WEN HUANG2023-12-112023-12-112023-1124680249https://scholars.lib.ntu.edu.tw/handle/123456789/637639Evocalcet is an oral calcimimetic agent with proven efficacy and safety in treating secondary hyperparathyroidism (SHPT) in Japanese patients on dialysis.enEast Asia; cinacalcet; evocalcet; gastrointestinal; randomized controlled trial; secondary hyperparathyroidism[SDGs]SDG2Comparison of the Oral Calcimimetics Evocalcet and Cinacalcet in East Asian Patients on Hemodialysis with Secondary Hyperparathyroidismjournal article10.1016/j.ekir.2023.08.034380252382-s2.0-85171549638https://api.elsevier.com/content/abstract/scopus_id/85171549638